<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Genmab — Februar 2026]]></title><description><![CDATA[<p dir="auto">Hvorfor stiger den pludselig godt 3%?</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/399205/genmab-februar-2026</link><generator>RSS for Node</generator><lastBuildDate>Sun, 07 Jun 2026 07:08:15 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/399205.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 02 Feb 2026 15:09:54 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Genmab — Februar 2026 on Fri, 27 Feb 2026 22:26:07 GMT]]></title><description><![CDATA[<p dir="auto">Så har vi den store uddeling af Warrants og især restricted Stocks.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686674</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686674</guid><dc:creator><![CDATA[bikube]]></dc:creator><pubDate>Fri, 27 Feb 2026 22:26:07 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Fri, 27 Feb 2026 15:30:04 GMT]]></title><description><![CDATA[<p dir="auto">yeah, it is month end... large auction not unusual</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686671</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686671</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Fri, 27 Feb 2026 15:30:04 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Fri, 27 Feb 2026 15:20:21 GMT]]></title><description><![CDATA[<p dir="auto">Hov- det var Novo, de handlede videre efter luk.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686670</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686670</guid><dc:creator><![CDATA[bikube]]></dc:creator><pubDate>Fri, 27 Feb 2026 15:20:21 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Fri, 27 Feb 2026 15:17:07 GMT]]></title><description><![CDATA[<p dir="auto">De blev ved med at handle mange tusind 4 minutter efter alm luk.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686673</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686673</guid><dc:creator><![CDATA[bikube]]></dc:creator><pubDate>Fri, 27 Feb 2026 15:17:07 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Fri, 27 Feb 2026 15:05:52 GMT]]></title><description><![CDATA[<p dir="auto">Noget af en omsætning i lukkeaktionen</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686669</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686669</guid><dc:creator><![CDATA[gdn55]]></dc:creator><pubDate>Fri, 27 Feb 2026 15:05:52 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Fri, 27 Feb 2026 14:08:24 GMT]]></title><description><![CDATA[<p dir="auto">FDA ansætter1000 flere medarbejdere for at kunne få flere ansøgninger igennem hurtigere.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686675</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686675</guid><dc:creator><![CDATA[bikube]]></dc:creator><pubDate>Fri, 27 Feb 2026 14:08:24 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Thu, 26 Feb 2026 21:02:05 GMT]]></title><description><![CDATA[<p dir="auto">44 dage med dette eksempel <a href="https://www.fda.gov/news-events/press-announcements/fda-grants-second-approval-under-national-priority-voucher-pilot-program" rel="nofollow ugc">https://www.fda.gov/news-events/press-announcements/fda-grants-second-approval-under-national-priority-voucher-pilot-program</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686667</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686667</guid><dc:creator><![CDATA[Solsen]]></dc:creator><pubDate>Thu, 26 Feb 2026 21:02:05 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Thu, 26 Feb 2026 20:38:09 GMT]]></title><description><![CDATA[<p dir="auto">FDAs Makary skaber virkelig forandring i godkendelsesprocessen. Reklamerer bl.a. med nedsættelse af procestiden fra et år til uger <a href="https://www.cnbc.com/video/2026/02/26/fda-commissioner-dr-makary-on-rare-disease-therapy-approvals-internal-politics-at-the-agency.html" rel="nofollow ugc">https://www.cnbc.com/video/2026/02/26/fda-commissioner-dr-makary-on-rare-disease-therapy-approvals-internal-politics-at-the-agency.html</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686666</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686666</guid><dc:creator><![CDATA[Solsen]]></dc:creator><pubDate>Thu, 26 Feb 2026 20:38:09 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Thu, 26 Feb 2026 18:34:27 GMT]]></title><description><![CDATA[<p dir="auto">"FDA vil give bonus for hurtigere gennem­gang af lægemidler", skriver Børsen</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686668</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686668</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Thu, 26 Feb 2026 18:34:27 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Thu, 26 Feb 2026 17:38:12 GMT]]></title><description><![CDATA[<p dir="auto">Abstract 2050: Preclinical characterization of PRO1106, a novel and promising SLITRK6-directed sesutecan ADC <a href="https://aacrjournals.org/cancerres/article/84/6_Supplement/2050/739213/Abstract-2050-Preclinical-characterization-of" rel="nofollow ugc">https://aacrjournals.org/cancerres/article/84/6_Supplement/2050/739213/Abstract-2050-Preclinical-characterization-of</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686672</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686672</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Thu, 26 Feb 2026 17:38:12 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Thu, 26 Feb 2026 17:37:19 GMT]]></title><description><![CDATA[<p dir="auto">Genmab taps ProfoundBio again <a href="https://www.oncologypipeline.com/apexonco/genmab-taps-profoundbio-again" rel="nofollow ugc">https://www.oncologypipeline.com/apexonco/genmab-taps-profoundbio-again</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686664</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686664</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Thu, 26 Feb 2026 17:37:19 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Thu, 26 Feb 2026 06:08:31 GMT]]></title><description><![CDATA[<p dir="auto">Asthika Goonewardene<br />
Truist Financial<br />
Buy $48.00 Reiterated 25-2-26</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686665</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686665</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Thu, 26 Feb 2026 06:08:31 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Wed, 25 Feb 2026 17:18:28 GMT]]></title><description><![CDATA[<p dir="auto">Genmab to Participate in Upcoming Investor Conferences <a href="https://ir.genmab.com/news-releases/news-release-details/genmab-participate-upcoming-investor-conferences" rel="nofollow ugc">https://ir.genmab.com/news-releases/news-release-details/genmab-participate-upcoming-investor-conferences</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686660</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686660</guid><dc:creator><![CDATA[Raun]]></dc:creator><pubDate>Wed, 25 Feb 2026 17:18:28 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Wed, 25 Feb 2026 09:18:25 GMT]]></title><description><![CDATA[<p dir="auto">Vi må heller ikke glemme at BioNTech var de første der smuttede</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686659</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686659</guid><dc:creator><![CDATA[Raun]]></dc:creator><pubDate>Wed, 25 Feb 2026 09:18:25 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Wed, 25 Feb 2026 09:01:25 GMT]]></title><description><![CDATA[<p dir="auto">Det samme skrev de i PM <a href="https://ir.genmab.com/news-releases/news-release-details/genmab-portfolio-prioritization-update/" rel="nofollow ugc">https://ir.genmab.com/news-releases/news-release-details/genmab-portfolio-prioritization-update/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686663</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686663</guid><dc:creator><![CDATA[Cupcake]]></dc:creator><pubDate>Wed, 25 Feb 2026 09:01:25 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Wed, 25 Feb 2026 09:00:35 GMT]]></title><description><![CDATA[<p dir="auto">Så skal man udlægge det positivt, så må det vel være, at de helt entydigt ser de tre fokus-stoffer som entydigt bedre muligheder med langt større potentiale ...</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686657</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686657</guid><dc:creator><![CDATA[gentogen]]></dc:creator><pubDate>Wed, 25 Feb 2026 09:00:35 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Wed, 25 Feb 2026 08:59:11 GMT]]></title><description><![CDATA[<p dir="auto">I øvrigt mener han at de tre hovedstoffer "let" kan dække for de indtægter, som de ellers havde signaleret forventning om</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686661</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686661</guid><dc:creator><![CDATA[gentogen]]></dc:creator><pubDate>Wed, 25 Feb 2026 08:59:11 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Wed, 25 Feb 2026 08:57:37 GMT]]></title><description><![CDATA[<p dir="auto">han er "ret overbevist" om, at de ville kunne få det på markedet og coteres for, at det var en "smertefuld" beslutning</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686655</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686655</guid><dc:creator><![CDATA[gentogen]]></dc:creator><pubDate>Wed, 25 Feb 2026 08:57:37 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Wed, 25 Feb 2026 08:56:25 GMT]]></title><description><![CDATA[<p dir="auto">Han siger, at det ikke ville være konkurrencedygtigt på grund af nye midler i 1. linje lungekræft, og blandt andet også på grund af prisen (kombinationen med Keytruda) som angiveligt ville være meget dyrere end nye monobehandlinger</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686654</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686654</guid><dc:creator><![CDATA[gentogen]]></dc:creator><pubDate>Wed, 25 Feb 2026 08:56:25 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Wed, 25 Feb 2026 08:55:49 GMT]]></title><description><![CDATA[<p dir="auto">Det er trods alt ikke lang tid siden de droppede stoffet og Genmab har jo også tidligere luftet tanken om en partner på stoffet - dog uden held. Men skønt vil det da være, hvis andre vil tage part eller forsøge at føre stoffet videre med store royalties til Genmab.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686662</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686662</guid><dc:creator><![CDATA[Raun]]></dc:creator><pubDate>Wed, 25 Feb 2026 08:55:49 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Wed, 25 Feb 2026 08:52:05 GMT]]></title><description><![CDATA[<p dir="auto">Nu kan jeg ikke læse artiklen. men udover det da lyder positivt at Genmab har haft "en del" henvendelser på stoffet. Så er der altså noget der lyder forkert.... Jeg er klar over at det er meget dyrt for Genmab at køre stoffet alene igennem et fase 3 studie og satsningen blev da også for stor. Men nu skal det hedde sig at JW er overbevist om at "hvis" de havde taget stoffet videre vil det nå markedet?... Der er for mig noget forkert i konteksten, når der nu skulle være interesser for stoffet.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686652</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686652</guid><dc:creator><![CDATA[Raun]]></dc:creator><pubDate>Wed, 25 Feb 2026 08:52:05 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Wed, 25 Feb 2026 08:40:33 GMT]]></title><description><![CDATA[<p dir="auto">It says that they have had "en del" henvendelser</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686651</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686651</guid><dc:creator><![CDATA[gentogen]]></dc:creator><pubDate>Wed, 25 Feb 2026 08:40:33 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Wed, 25 Feb 2026 08:39:23 GMT]]></title><description><![CDATA[<p dir="auto">No. Just now I was able to read the whole text. So try again. Jan mentions that they continue treating the patients enrolled in the phase 3.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686658</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686658</guid><dc:creator><![CDATA[gentogen]]></dc:creator><pubDate>Wed, 25 Feb 2026 08:39:23 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Februar 2026 on Wed, 25 Feb 2026 07:43:44 GMT]]></title><description><![CDATA[<p dir="auto">does it mention what companies are<br />
showing interest?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7686656</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7686656</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Wed, 25 Feb 2026 07:43:44 GMT</pubDate></item></channel></rss>